Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04522999 · ClinicalTrials.gov registry record · NA
Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration
A NA study, sponsored by LumiThera.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04522999 is a NA study that has completed, run by LumiThera. The registered enrollment target is 15 participants.
The verdict
NCT04522999, a NA study, has completed, sponsored by LumiThera.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
To evaluate the ability of Photobiomodulation (PBM) treatment using the Valeda® Light Delivery System to improve Electroretinogram (ERG) outcomes in subjects with dry Age-related Macular Degeneration (AMD).
Interventions
- DEVICE Photobiomodulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2021-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04522999
The ClinicalTrials.gov registry entry for NCT04522999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LumiThera, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Photobiomodulation is the first listed.
NCT04522999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04522999 about?
NCT04522999 is a clinical study titled "Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration". To evaluate the ability of Photobiomodulation (PBM) treatment using the Valeda® Light Delivery System to improve Electroretinogram (ERG) outcomes in subjects with dry Age-related Macular Degeneration (AMD).
What is the current status of trial NCT04522999?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2020-08-20. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT04522999?
The interventions under investigation include: Photobiomodulation (DEVICE).
Who is sponsoring clinical trial NCT04522999?
This trial is sponsored by LumiThera, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.